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of ischemic lesions (the Alberta Stroke Program Early Computed Tomography Score [ASPECTS] ) have been shown to be reproducible in both CT and MR imaging, and to be an independent predictor of 3-month outcome. [7] [8] [9] We, therefore, aimed to adapt the CT-DRAGON score to patients with anterior circulation stroke imaged by MRI and treated by IV-tPA within 4.5 hours. We derived the new MRI-DRAGON score from our single-center cohort of thrombolyzed stroke patients and performed an internal cross-validation.
Methods Population
We reviewed all consecutive ischemic stroke patients treated within 4.5 hours by IV-tPA between November 2003 and February 2012. MRI is systematically implemented in our center as first-line diagnostic work-up in candidates for thrombolysis, in the absence of contraindications to MRI. In this analysis, we included all patients with anterior circulation stroke and who had MRI. Age, National Institutes of Health Stroke Scale score on admission, blood pressure, and serum glucose level before treatment, prestroke modified Rankin Scale (mRS) score, and OTT were collected in a standardized medical chart. Outcomes at 3 months were assessed by a neurologist 10 and classified as good (mRS, ≤2), poor (mRS, [3] [4] [5] [6] , or miserable (mRS, ≥5), according to the CT-DRAGON score publication. 6 In accordance with the French legislation, the study did not need approval by an Ethics Committee nor written informed consent from patients, because it implied only retrospective analysis of anonymized data collected prospectively as part of routine clinical care.
MRI Analysis
The MR protocol included diffusion-weighted imaging (DWI; singleshot echo-planar spin-echo sequence; 3 directions, b=1000 s/mm 2 ), Fluid Attenuated Inversion Recovery, T2* and intracranial time-offlight MR angiography (MRA), performed on a 1.5-T scanner. The CT-DRAGON score, designed for CT imaging, includes 2 radiological variables: the hyperdense MCA sign and early signs of infarction. We adapted these factors and considered proximal (M1) MCA occlusion on MRA and DWI ASPECTS. 8 Any proximal (M1) MCA occlusion was considered, irrespective of the status of the other arteries. On a picture archiving and communication system workstation, 1 neurologist blinded to clinical outcome scored DWI ASPECTS on pretreatment MRI according to the method described by Barber, from 2 standard axial sections: 1 at the level of the thalamus and basal ganglia, and the other just rostral to the ganglionic structures. 7 A score of 10 indicates the absence of MCA territory infarction, and a score of 0, complete infarction throughout this territory. One month after the initial DWI ASPECTS scoring, 60 MRIs were randomly selected and re-evaluated by the same reader and by an experienced neuroradiologist to assess intra-and interobserver agreements. The DWI ASPECTS score was then dichotomized into >5 versus ≤5. 9 However, because there is a controversy over the best DWI ASPECTS threshold to predict clinical outcome, we performed additional analyses using the ≤7 cut-off. 7, 11 Finally, because MRA provides information on all intracranial arteries, we performed additional analyses considering any anterior circulation artery occlusion (internal carotid artery, M1, or M2 segment of the MCA, or anterior cerebral artery) instead of M1 occlusion only.
Statistical Analysis
Continuous variables with a normal distribution were described as mean±SD and non-normally distributed variables were described as median and interquartile range. Variables were compared using t test, Pearson χ 2 , or Fisher exact test, as appropriate. Clinical variables were categorized using the previously published cut-offs of the CT-DRAGON score. 6 Intra-and interobserver agreements for each 
Results
During the study period, 271 consecutive patients were treated with IV-tPA ≤4.5 hours after stroke onset, without additional endovascular therapy. For the present analysis, 40 patients were not eligible because of permanent or temporary contraindication to MRI at admission (n=19), posterior circulation stroke (n=19), or important motion artifacts on DWI or MRA (n=2). Furthermore, 3-month outcome was missing for 3 patients, leaving 228 patients for analysis. Patients' characteristics are summarized in Table I in the online-only Data Supplement. One hundred twenty-two (54%) patients were men, mean age was 67.3±14.9 years, median (interquartile range) National Institutes of Health Stroke Scale score at admission was 14 (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) , and mean OTT was 162±47 minutes. Six patients had a prestroke mRS >1 (mRS>2 for 1 patient). At 3 months, 98 (43%) patients had a poor outcome, including 42 (18%) with a miserable outcome. In univariate and multivariate analyses, poor outcome was significantly associated with most of the CT-DRAGON clinical variables: National Institutes of Health Stroke Scale score on admission, age, and glucose level on admission >8 mmol/L (Table 1) . There was a nonsignificant trend for the association between poor outcome and OTT>90 minutes and prestroke mRS>1. The radiological variables proposed for the MRI-DRAGON score (MCA occlusion and DWI ASPECTS ≤ 5) were strongly associated with poor outcome. Similarly, there was a significant association between outcome and DWI ASPECTS ≤7. Using the MRI-DRAGON score (Table 2) , the c-statistic was 0.83 (95% CI, 0.78-0.88) for predicting poor outcome. This c-statistic was significantly higher than that of the model including only the clinical variables (c-statistic=0.79; 95% CI, 0.73-0.84; P=0.002 for comparison; Figure 1 ). In sensitivity analyses, the c-statistic of an alternative model including a ≤7 instead of the ≤5 DWI ASPECTS cut-off was 0.82 (95% CI, 0.77-0.88). The predictive ability of the model was also similar if 3-month poor outcome was defined as mRS >1 instead of mRS >2 (125 patients with mRS>1; c-statistic=0.83; 0.78-0.88). Finally, we tested the predictive ability of an alternative MRI-DRAGON score considering any anterior circulation artery occlusion and found a similar Figure 2 . In our cohort, all patients who had ≤2 points (n=22) had a good 3-month outcome, whereas all patients who had ≥8 points (n=11) had a poor outcome. Sensitivity and specificity for each individual MRI-DRAGON score values are presented in Table II in the online-only Data Supplement.
Discussion
Using the original CT-DRAGON score, 6 we have derived and internally cross-validated the MRI-DRAGON score, a simple tool that can reliably predict the 3-month outcome of acute stroke patients imaged by MRI and treated by IV-tPA within 4.5 hours. The MRI-DRAGON score consists of 5 clinical parameters available at bedside and 2 straightforward MRI parameters.
Our results suggest that the MRI-DRAGON score could be of clinical importance for several reasons. First, it can provide physicians with an estimation of their patient's 3-month prognosis, and therefore help them for families' information. Second, the MRI-DRAGON score could be used to identify quickly moderately severe patients (ie, patients scoring, 5-7), who are at risk of clinical worsening and may be considered for additional vessel status assessment soon after IV-tPA and for potentially endovascular interventions. 12 This subgroup could be the focus of an endovascular trial testing the benefit of bridging therapy. In our study, the MRI-DRAGON score showed a high specificity in extreme values, as all patients with a ≤2 score had a good outcome, whereas all patients with a ≥8 score had a poor outcome. The 3-month outcome of 33 (15%) patients could, therefore, be predicted with a complete accuracy in our population.
All clinical parameters of the CT-DRAGON score were independently associated with 3-month outcome in our study, although not statistically significant for OTT. The MRI-DRAGON score incorporates the DWI ASPECTS score, which has been shown to be an independent 3-month outcome predictor, and to be assessable with good intra and interrater agreement. 8, 13 Although a ≤7 ASPECTS cut-off was most often used in prognostic studies using CT, 7, 14 we chose a ≤5 threshold for the MRI-DRAGON score because DWI ASPECTS was lower than CT ASPECTS, 9, 15 and because this cut-off was associated with a slightly better reproducibility in our study. However, sensitivity analyses using a ≤7 instead of ≤5 DWI ASPECTS cut-off for the MRI-DRAGON score showed a similar c-statistic.
The CT-DRAGON score included the hyperdense MCA sign on CT-scanner, which has been shown to be a predictor of poor 3-month outcome. 16 Although previous studies suggested that tandem internal carotid artery-MCA occlusion might have a better predictive value of poor outcome, we decided to include proximal (M1) MCA occlusion on MRA (timeof-flight imaging), to be as close as possible to the original score. 17 Furthermore, using tandem internal carotid artery-MCA, instead of M1 occlusion, did not improve the c-statistic (0.84; 95% CI, 0.79-0.89) of the MRI-DRAGON score in our study (P=0.70 for comparison).
Several other scores can be used to estimate long-term outcome in patients treated by IV-tPA for acute ischemic stroke, but very few were specifically designed for this purpose. A simple clinical and MRI score to predict 3-month mRS ≥4 has been recently derived in a Japanese cohort of patients treated by IV-tPA within 3 hours. The authors were able to predict with certainty poor outcome in 19 of 117 (16%) patients in the derivation cohort. However, no internal or external validation was performed, and the c-statistic was not reported. 15 Of note, the c-statistic of this score applied to our population was 0.74 Other scores that may be used to predict outcome of acute stroke patients were initially designed to predict the risk of bleeding, 18 the risk of death after stroke, 19 to help decision making, 20 or were not specifically evaluated in patients with IV-tPA. 21 Moreover, some of these scores include parameters hardly available at inclusion, such as stroke etiology, 19 or variables that represent a contraindication for IV-tPA, such as an impairment of consciousness. 21 Our study has several potential limitations. First, we did not perform an external validation. However, because we just made minor modifications to the CT-DRAGON score to be applicable in patients investigated by MRI, our approach could be considered as an adaptation rather than the development of a new score. Second, in the absence of concomitant CT imaging, it is unknown whether the MRI-DRAGON score has a better prognostic performance than the CT-DRAGON score. The direct comparison of c-statistics between the 2 studies cannot be performed. However, the proportion of patients with a 3-month outcome predicted as good or poor with certainty in our study was similar (15%) to that predicted in the CT-DRAGON study (12%). Third, as we only included anterior circulation stroke patients, our findings cannot apply to patients with vertebrobasilar stroke. The CT-DRAGON investigators considered their score to be applicable to all patients apart from those presenting with basilar artery occlusion. 6 However, this score takes into account the MCA hyperdense sign but not signs of occlusion in the posterior circulation territory. Furthermore, it is unclear how early CT ischemic changes in this territory have been assessed. Further data will be needed to assess whether the MRI-DRAGON score can be adapted for posterior circulation stroke patients (eg, using the previously described posterior DWI ASPECTS score). 22 Fourth, such as the previously published prognostic scores for patients with acute stroke, the MRI-DRAGON score was of little help for outcome prediction in patients with a midrange score (ie, 5 or 6). 15, 21 Although refinements of the MRI-DRAGON score could derive from adding more detailed clinical and imaging data, our aim was to develop a simple tool, including only variables easily available at admission. Finally, MRA provides more information on vessel status than noncontrast CT and we did not consider all arterial occlusions in the MRI-DRAGON score. However, the inclusion of smaller arteries or more distal segments did not improve the predictive ability of the score as shown in our sensitivity analyses. Indeed, occlusions of small arteries or branches are less likely to predict poor outcome than M1-MCA occlusion.
In conclusion, the MRI-DRAGON score is a new pragmatic tool to predict 3-month outcome in patients treated by IV-tPA for acute ischemic stroke and imaged by MRI. It might be used to select good candidates for additional therapeutic strategies. 
